Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 15.66
(-1.39%)
CNY 15.66
(-1.39%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 426.52 Million CNY | 33.78% |
| 2022 | 318.82 Million CNY | 16.53% |
| 2021 | 273.58 Million CNY | 35.82% |
| 2020 | 201.44 Million CNY | 0.09% |
| 2019 | 201.26 Million CNY | -18.27% |
| 2018 | 246.26 Million CNY | -7.27% |
| 2017 | 265.56 Million CNY | 26.23% |
| 2016 | 210.38 Million CNY | 5.95% |
| 2015 | 198.56 Million CNY | 172.72% |
| 2014 | 72.8 Million CNY | 89.64% |
| 2013 | 38.39 Million CNY | 56.05% |
| 2012 | 24.6 Million CNY | 41.83% |
| 2011 | 17.34 Million CNY | 18.52% |
| 2010 | 14.63 Million CNY | -16.9% |
| 2009 | 17.61 Million CNY | 52.34% |
| 2008 | 11.56 Million CNY | -30.33% |
| 2007 | 16.59 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 478.55 Million CNY | -5.42% |
| 2024 Q2 | 505.98 Million CNY | 16.44% |
| 2024 Q1 | 434.54 Million CNY | 1.88% |
| 2023 FY | 426.52 Million CNY | 33.78% |
| 2023 Q2 | 397.69 Million CNY | 7.22% |
| 2023 Q1 | 370.92 Million CNY | 16.34% |
| 2023 Q3 | 400.31 Million CNY | 0.66% |
| 2023 Q4 | 426.52 Million CNY | 6.55% |
| 2022 Q4 | 318.82 Million CNY | 12.83% |
| 2022 Q2 | 272.17 Million CNY | 8.88% |
| 2022 Q1 | 249.97 Million CNY | -8.63% |
| 2022 FY | 318.82 Million CNY | 16.53% |
| 2022 Q3 | 282.58 Million CNY | 3.82% |
| 2021 Q2 | 218.42 Million CNY | 0.36% |
| 2021 Q1 | 217.63 Million CNY | 8.04% |
| 2021 FY | 273.58 Million CNY | 35.82% |
| 2021 Q4 | 273.58 Million CNY | 29.59% |
| 2021 Q3 | 211.11 Million CNY | -3.35% |
| 2020 Q3 | 197.81 Million CNY | -1.85% |
| 2020 Q2 | 201.54 Million CNY | -3.98% |
| 2020 FY | 201.44 Million CNY | 0.09% |
| 2020 Q1 | 209.89 Million CNY | 4.29% |
| 2020 Q4 | 201.44 Million CNY | 1.83% |
| 2019 FY | 201.26 Million CNY | -18.27% |
| 2019 Q3 | 207.9 Million CNY | -7.42% |
| 2019 Q1 | 242.4 Million CNY | -1.57% |
| 2019 Q2 | 224.57 Million CNY | -7.35% |
| 2019 Q4 | 201.26 Million CNY | -3.19% |
| 2018 Q3 | 271.28 Million CNY | 0.7% |
| 2018 Q2 | 269.38 Million CNY | -9.02% |
| 2018 FY | 246.26 Million CNY | -7.27% |
| 2018 Q1 | 296.09 Million CNY | 11.5% |
| 2018 Q4 | 246.26 Million CNY | -9.22% |
| 2017 Q2 | 230.46 Million CNY | -1.06% |
| 2017 Q3 | 273.67 Million CNY | 18.75% |
| 2017 Q4 | 265.56 Million CNY | -2.97% |
| 2017 Q1 | 232.92 Million CNY | 10.72% |
| 2017 FY | 265.56 Million CNY | 26.23% |
| 2016 Q1 | 190.53 Million CNY | -4.04% |
| 2016 Q4 | 210.38 Million CNY | 2.22% |
| 2016 FY | 210.38 Million CNY | 5.95% |
| 2016 Q3 | 205.81 Million CNY | 8.38% |
| 2016 Q2 | 189.89 Million CNY | -0.33% |
| 2015 Q2 | 91.72 Million CNY | 17.18% |
| 2015 FY | 198.56 Million CNY | 172.72% |
| 2015 Q4 | 198.56 Million CNY | 8.92% |
| 2015 Q1 | 78.27 Million CNY | 7.51% |
| 2015 Q3 | 182.3 Million CNY | 98.75% |
| 2014 Q4 | 72.8 Million CNY | 21.63% |
| 2014 FY | 72.8 Million CNY | 89.64% |
| 2014 Q3 | 59.85 Million CNY | 24.18% |
| 2014 Q2 | 48.2 Million CNY | 10.47% |
| 2014 Q1 | 43.63 Million CNY | 13.66% |
| 2013 Q3 | 30.47 Million CNY | 6.66% |
| 2013 Q4 | 38.39 Million CNY | 25.99% |
| 2013 FY | 38.39 Million CNY | 56.05% |
| 2013 Q1 | 27.32 Million CNY | 11.08% |
| 2013 Q2 | 28.57 Million CNY | 4.55% |
| 2012 FY | 24.6 Million CNY | 41.83% |
| 2012 Q2 | 17.56 Million CNY | 10.04% |
| 2012 Q3 | 22.67 Million CNY | 29.12% |
| 2012 Q4 | 24.6 Million CNY | 8.48% |
| 2012 Q1 | 15.96 Million CNY | -7.98% |
| 2011 Q3 | 16.74 Million CNY | -6.77% |
| 2011 FY | 17.34 Million CNY | 18.52% |
| 2011 Q4 | 17.34 Million CNY | 3.63% |
| 2011 Q1 | 15.63 Million CNY | 6.83% |
| 2011 Q2 | 17.95 Million CNY | 14.84% |
| 2010 Q2 | 17.45 Million CNY | 0.0% |
| 2010 FY | 14.63 Million CNY | -16.9% |
| 2010 Q4 | 14.63 Million CNY | 0.0% |
| 2009 FY | 17.61 Million CNY | 52.34% |
| 2008 FY | 11.56 Million CNY | -30.33% |
| 2007 FY | 16.59 Million CNY | 0.0% |